Tributyl CITRATE (cas 13754-17-1) as an effective plasticizer for biodegradable polymers: effect of plasticizer on free volume and transport and mechanical properties
-
Add time:09/30/2019 Source:infona.pl
The effectiveness of tributyl CITRATE (cas 13754-17-1) (TbC) as a plasticizer for polylactide and polyhydroxybutyrate was analysed in order to improve the ductility of these polymers and make them good candidates for food packaging applications. Although the thermal and mechanical properties have been widely studied in the literature, the effect of the plasticizer on free volume and transport properties has not been deeply analysed. The free volume was characterized using positron annihilation lifetime spectroscopy observing its linear increase with TbC content. The permeability to water vapour, oxygen and carbon dioxide was determined and the obtained results were related to the changes in glass transition temperature, level of crystallinity of the samples and free volume. This work would allow a better understanding of the effect of the plasticizer on the barrier and mechanical properties of polymers allowing the development of competitive materials for packaging applications. © 2018 Society of Chemical Industry
We also recommend Trading Suppliers and Manufacturers of CITRATE (cas 13754-17-1). Pls Click Website Link as below: cas 13754-17-1 suppliers
Prev:Effect of trisodium CITRATE (cas 13754-17-1) on electrolytic deposition of hydroxyapatite coatings
Next:An unexpected cyclization discovered during the synthesis of 8-substituted purines from a 4,5-Diaminopyrimidine (cas 13754-19-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effect of trisodium CITRATE (cas 13754-17-1) on electrolytic deposition of hydroxyapatite coatings09/29/2019
- Structures of mesophilic and extremophilic CITRATE (cas 13754-17-1) synthases reveal rigidity and flexibility for function09/28/2019
- Combined pioglitazone–metformin and clomiphene CITRATE (cas 13754-17-1) versus metformin and clomiphene CITRATE (cas 13754-17-1) in induction of ovulation in women with clomiphene CITRATE (cas 13754-17-1)-resistant polycystic ovary syndrome10/01/2019
- Effects of mosapride CITRATE (cas 13754-17-1), metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride CITRATE (cas 13754-17-1) on equine gastric emptying, small intestinal and caecal motility09/27/2019
- A randomized controlled trial of the efficacy of rosiglitazone and clomiphene CITRATE (cas 13754-17-1) versus metformin and clomiphene CITRATE (cas 13754-17-1) in women with clomiphene CITRATE (cas 13754-17-1)–resistant polycystic ovary syndrome09/26/2019
- Observational Study of Need for Thrombolytic Therapy and Incidence of Bacteremia using Taurolidine‐CITRATE (cas 13754-17-1)‐Heparin, Taurolidine‐CITRATE (cas 13754-17-1) and Heparin Catheter Locks in Patients Treated with Hemodialysis09/25/2019